*Some Market data delayed by 15 mins.

CASI Pharmaceuticals, Inc. Ordinary Shares

Symbol: CASI (NASDAQ)
1.87 ▲ (6.86%) 0.120

Company Description:
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Key Stats
  • Today's Open: $1.85
  • Today's High: $2.06
  • Today's Low: $1.745
  • Today's Volume: 188.01K
  • Yesterday Close: $1.75
  • Yesterday High: $1.9191
  • Yesterday Low: $1.7
  • Yesterday Volume: 163.45K
  • Last Min Volume: 102
  • Last Min High: $1.87
  • Last Min Low: $1.87
  • Last Min VWAP: $1.87
Company Profile
  • Name: CASI Pharmaceuticals, Inc. Ordinary Shares
  • Website: https://www.casipharmaceuticals.com
  • Listed Date: 1996-06-12
  • Location: ,
  • Market Status: Active
  • CIK Number: 0001962738
  • SIC Code:
  • SIC description:
  • Market Cap: $28.66M
  • Round Lot: 100
  • Outstanding Shares: 15.49M
  • Asset Type: CS
RECENT FILINGS FOR CASI
Filing Date Filing Type Format
2025-09-26 SCHEDULE 13D View
2025-09-26 6-K View
2025-09-02 6-K View
2025-08-29 6-K View
2025-08-27 6-K View
2025-08-12 SCHEDULE 13G/A View
2025-08-04 6-K View
2025-07-23 SCHEDULE 13G/A View
2025-07-22 6-K View
2025-06-20 SCHEDULE 13D/A View
2025-05-20 6-K View
2025-05-20 6-K/A View
2025-05-16 6-K View
2025-05-14 6-K View
2025-05-12 6-K View
2025-05-07 6-K View
2025-04-09 6-K View
2025-04-03 6-K View
2025-04-03 6-K View
2025-04-01 424B5 View
Latest News on CASI

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.